Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 14, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	8,486	4,461	3,908	3,497	2,721	2,266
Market Cap Growth	8.40%	14.13%	11.76%	28.52%	20.11%	-7.39%
Enterprise Value	8,968	5,080	4,148	3,763	3,110	2,513
Last Close Price	38.05	20.00	20.90	18.70	14.55	13.39
PE Ratio	71.26	200.14	-	-	-	-
PS Ratio	7.96	5.01	7.64	7.55	6.60	6.41
PB Ratio	4.79	2.67	3.59	3.13	2.24	2.30
P/TBV Ratio	4.76	3.92	3.63	3.17	2.28	2.37
P/OCF Ratio	35.40	-	343.32	-	-	-
EV/Sales Ratio	8.42	5.71	8.10	8.12	7.55	7.11
EV/EBITDA Ratio	32.08	36.55	333.67	-	-	-
EV/EBIT Ratio	62.27	208.88	-	-	-	-
Debt / Equity Ratio	0.37	0.43	0.47	0.37	0.27	0.37
Debt / EBITDA Ratio	2.37	4.52	20.74	-	-	-
Asset Turnover	0.41	0.40	0.28	0.26	0.25	0.23
Inventory Turnover	2.03	1.97	2.03	2.17	2.67	3.20
Quick Ratio	0.71	0.53	0.51	0.55	1.08	0.45
Current Ratio	1.32	1.10	1.21	1.05	1.73	0.91
Return on Equity (ROE)	6.97%	1.61%	-2.61%	-8.80%	-15.56%	-18.60%
Return on Assets (ROA)	3.48%	0.69%	-1.44%	-4.76%	-6.30%	-8.32%
Return on Capital (ROIC)	3.74%	0.76%	-1.67%	-5.43%	-7.20%	-9.60%
Return on Capital Employed (ROCE)	7.05%	1.22%	-	-	-	-
Earnings Yield	1.40%	0.50%	-0.74%	-2.94%	-6.30%	-8.87%
FCF Yield	1.71%	-3.52%	-0.44%	-3.43%	-8.17%	-6.86%
Buyback Yield / Dilution	-8.79%	-19.27%	0.00%	-10.40%	-8.57%	-0.15%
Total Shareholder Return	-8.79%	-19.27%	0.00%	-10.40%	-8.57%	-0.15%

Source: S&P Capital IQ. Standard template. Financial Sources.